ASPHALION REGTALK | CLINICAL TRIALS INFORMATION SYSTEM

At ASPHALION, we invite you to our second “RegTalk”, one-to-one talks carried out by experts in different areas, aimed at informing about the latest news in the Regulatory Affairs landscape.

At ASPHALION, we invite you to our second “RegTalk”, one-to-one talks carried out by experts in different areas, aimed at informing about the latest news in the Regulatory Affairs landscape.
August 5, 2021

At ASPHALION, we invite you to our second “RegTalk”, one-to-one talks carried out by experts in different areas, aimed at informing about the latest news in the Regulatory Affairs landscape.

In this occasion, we would like to get you acquainted with the Clinical Trials Information System. Our experts, Christopher Mann, PhD, Scientific and Regulatory Affairs Director and Nuria García Pazos, Senior Regulatory Affairs Officer and Project Manager at ASPHALION will provide you with an overview about CTIS, which will be the single entry point for submitting clinical trials information in the EU once it becomes applicable, foreseeable on January 31st, 2022.

We hope the content will be of your interest and you will find it valuable.

Enjoy our RegTalk: “Key factors about the implementation of the new Clinical Trials Information System (CTIS)”

For futher information, you can contact us at:

info@asphalion.com

You can watch the whole RegTalk here:

ASPHALION REGTALK | CLINICAL TRIALS INFORMATION SYSTEM

Search News & Events

  • Filter by category

Share

Related news and events

EVENT | 20th Biosimilar Medicines Conference by MFE

During these two interactive days, actors of the healthcare community alongside world experts in biosimilar medicines will gather and debate the evolving biosimilar medicines landscape and emerging trends. Discussion will focus on sharing good practices and setting collective aims to achieve the depth, breadth and speed of the use of biosimilar medicines as a lever to untap their transformative value.

BUSINESS CASE | Transparency policy 0070

Have a look at this Business Case where Asphalion provided a leading global pharmaceutical company with full regulatory support for the management of Policy 0070

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting